Variant report

Variant	nsv963066
Chromosome Location	chr19:52150359-52154682
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ATF2	chr19:52154376-52154835	GM12878	blood:	n/a	n/a
2	BHLHE40	chr19:52150088-52150405	K562	blood:	n/a	chr19:52150169-52150178 chr19:52150169-52150178
3	BHLHE40	chr19:52150049-52150408	GM12878	blood:	n/a	chr19:52150169-52150178 chr19:52150169-52150178
4	BHLHE40	chr19:52154406-52154749	GM12878	blood:	n/a	n/a
5	CTCF	chr19:52154452-52154497	GM13976	blood:	n/a	chr19:52154471-52154492
6	CTCF	chr19:52150420-52150570	GM12872	blood:	n/a	n/a
7	CTCF	chr19:52154501-52154511	K562	blood:	n/a	n/a
8	E2F6	chr19:52154403-52154586	K562	blood:	n/a	chr19:52154461-52154473
9	EBF1	chr19:52154495-52154829	GM12878	blood:	n/a	n/a
10	EGR1	chr19:52154545-52154762	GM12878	blood:	n/a	chr19:52154684-52154697 chr19:52154681-52154695
11	EP300	chr19:52150197-52150372	GM12878	blood:	n/a	n/a
12	FOXM1	chr19:52154399-52154890	GM12878	blood:	n/a	n/a
13	IKZF1	chr19:52154398-52154669	GM12878	blood:	n/a	n/a
14	JUND	chr19:52154658-52155015	K562	blood:	n/a	chr19:52154700-52154711
15	MAX	chr19:52154479-52154498	GM12878	blood:	n/a	n/a
16	MTA3	chr19:52154332-52154895	GM12878	blood:	n/a	n/a
17	NFIC	chr19:52154380-52154880	GM12878	blood:	n/a	n/a
18	NFIC	chr19:52149836-52150411	GM12878	blood:	n/a	n/a
19	PAX5	chr19:52154479-52154964	GM12878	blood:	n/a	n/a
20	POLR2A	chr19:52149758-52150428	GM12891	blood:	n/a	n/a
21	RELA	chr19:52154425-52155073	GM18951	blood:	n/a	n/a
22	RELA	chr19:52154359-52154913	GM19099	blood:	n/a	n/a
23	RELA	chr19:52154393-52155191	GM18505	blood:	n/a	n/a
24	REST	chr19:52154429-52154703	Hela-S3	cervix:	n/a	n/a
25	REST	chr19:52154660-52155245	HL-60	blood:	n/a	chr19:52154699-52154712
26	RUNX3	chr19:52154331-52154877	GM12878	blood:	n/a	n/a
27	RUNX3	chr19:52150128-52150438	GM12878	blood:	n/a	n/a
28	RUNX3	chr19:52150121-52150448	GM12878	blood:	n/a	n/a
29	RUNX3	chr19:52154382-52154805	GM12878	blood:	n/a	n/a
30	SPI1	chr19:52149758-52150421	GM12878	blood:	n/a	chr19:52149949-52149962 chr19:52150152-52150165 chr19:52150154-52150163
31	SPI1	chr19:52154501-52155241	HL-60	blood:	n/a	chr19:52155121-52155134 chr19:52155083-52155096 chr19:52154651-52154660 chr19:52154909-52154918 chr19:52154906-52154919 chr19:52154588-52154601 chr19:52154910-52154917 chr19:52154907-52154920
32	SPI1	chr19:52154415-52155180	GM12891	blood:	n/a	chr19:52155121-52155134 chr19:52155083-52155096 chr19:52154651-52154660 chr19:52154909-52154918 chr19:52154906-52154919 chr19:52154588-52154601 chr19:52154910-52154917 chr19:52154907-52154920
33	SPI1	chr19:52154449-52154781	GM12878	blood:	n/a	chr19:52154651-52154660 chr19:52154588-52154601
34	SPI1	chr19:52154503-52154738	GM12878	blood:	n/a	chr19:52154651-52154660 chr19:52154588-52154601
35	SPI1	chr19:52154377-52154911	GM12891	blood:	n/a	chr19:52154651-52154660 chr19:52154588-52154601
36	SPI1	chr19:52154108-52155293	GM12878	blood:	n/a	chr19:52155121-52155134 chr19:52155083-52155096 chr19:52154651-52154660 chr19:52154909-52154918 chr19:52154906-52154919 chr19:52154588-52154601 chr19:52154910-52154917 chr19:52154907-52154920
37	SPI1	chr19:52154456-52155335	HL-60	blood:	n/a	chr19:52155121-52155134 chr19:52155083-52155096 chr19:52154651-52154660 chr19:52154909-52154918 chr19:52154906-52154919 chr19:52154588-52154601 chr19:52154910-52154917 chr19:52154907-52154920
38	TCF3	chr19:52154434-52154837	GM12878	blood:	n/a	n/a
39	TEAD4	chr19:52154616-52155007	K562	blood:	n/a	n/a
40	YY1	chr19:52154441-52154852	GM12878	blood:	n/a	chr19:52154460-52154468
41	YY1	chr19:52150142-52150406	GM12891	blood:	n/a	n/a
42	ZBTB7A	chr19:52150306-52150427	K562	blood:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr19:52150547-52150597	AG10803	skin:	n/a
2	chr19:52150547-52150597	AG10803	skin:	n/a
3	chr19:52150634-52150684	AG09309	skin:	n/a
4	chr19:52150634-52150684	MCF-7	breast:	n/a
5	chr19:52150634-52150684	HNPCEpiC	eye:	n/a
6	chr19:52150547-52150597	AoSMC	blood vessel:	n/a
7	chr19:52150547-52150597	SK-N-SH_RA	brain:	n/a
8	chr19:52150547-52150597	NH-A	brain:	n/a
9	chr19:52150547-52150597	HRE	kidney:	n/a
10	chr19:52150634-52150684	SAEC	small airway:	n/a
11	chr19:52150634-52150684	A549	lung:	n/a
12	chr19:52150547-52150597	HIPEpiC	eye:	n/a
13	chr19:52150547-52150597	ECC-1	luminal epithelium:	n/a
14	chr19:52150634-52150684	CMK	blood:	n/a
15	chr19:52150547-52150597	PrEC	prostate:	n/a
16	chr19:52150547-52150597	NT2-D1	testis:	n/a
17	chr19:52150634-52150684	AG10803	skin:	n/a
18	chr19:52150547-52150597	PANC-1	pancreas:	n/a
19	chr19:52150547-52150597	GM12891	blood:	n/a
20	chr19:52150634-52150684	HCF	heart:	n/a
21	chr19:52150634-52150684	SK-N-MC	brain:	n/a
22	chr19:52150634-52150684	MCF10A-Er-Src	breast:	n/a
23	chr19:52150547-52150597	IMR90	lung:	fetal
24	chr19:52150634-52150684	HepG2	liver:	n/a
25	chr19:52150547-52150597	BJ	skin:	n/a
26	chr19:52150547-52150597	HPAEpiC	pulmonary alveolar:	n/a
27	chr19:52150634-52150684	SKMC	muscle:	n/a
28	chr19:52150634-52150684	LNCaP	prostate:	n/a
29	chr19:52150547-52150597	GM19239	blood:	n/a
30	chr19:52150547-52150597	Hela-S3	cervix:	n/a
31	chr19:52150547-52150597	HCM	heart:	n/a
32	chr19:52150547-52150597	Caco-2	colon:	n/a
33	chr19:52150547-52150597	AG04450	lung:	fetal
34	chr19:52150547-52150597	ProgFib	skin:	n/a
35	chr19:52150547-52150597	CMK	blood:	n/a
36	chr19:52150634-52150684	HUVEC	blood vessel:	n/a
37	chr19:52150634-52150684	HRCEpiC	kidney:	n/a
38	chr19:52150634-52150684	HEK293	kidney:	embryo
39	chr19:52150547-52150597	HCT-116	colon:	n/a
40	chr19:52150634-52150684	PFSK-1	brain:	n/a
41	chr19:52150547-52150597	HEEpiC	esophagus:	n/a
42	chr19:52150634-52150684	HRPEpiC	eye:	n/a
43	chr19:52150634-52150684	HL-60	blood:	n/a
44	chr19:52150634-52150684	AG04450	lung:	fetal
45	chr19:52150547-52150597	HL-60	blood:	n/a
46	chr19:52150547-52150597	SK-N-MC	brain:	n/a
47	chr19:52150634-52150684	HMEC	breast:	n/a
48	chr19:52150547-52150597	HCPEpiC	choroid plexus:	n/a
49	chr19:52150547-52150597	GM12892	blood:	n/a
50	chr19:52150547-52150597	LNCaP	prostate:	n/a

No.	Distal block	Cell Line	Cell type	Cell Stage
1	chr19:51965493..51967976-chr19:52153295..52156025,2	K562	blood:
2	chr19:51873847..51875580-chr19:52152831..52155624,2	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-ZNF175-5	chr19:52152115-52152863	NONHSAT067458

Variant related genes	Relation type
SIGLEC14	TF binding region
ENSG00000268500	TF binding region
RPL7P51	TF binding region
SIGLEC5	TF binding region
SIGLEC14	CpG island
ENSG00000268500	CpG island
RPL7P51	CpG island
SIGLEC5	CpG island

Extended variants
information (count: 237 )
Associated
traits (count: 65 )

Variant overlapped rSNPs/rCNVs (count:237 , 50 per page) page: 1 2 3 4 5

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs192177671	chr19:52150361-52150362	Bivalent Enhancer Enhancers Flanking Active TSS Active TSS Weak transcription	TF binding region	4 gene(s)	Overlapped CNVs	n/a
2	rs545833523	chr19:52150400-52150401	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Bivalent/Poised TSS	TF binding region	4 gene(s)	Overlapped CNVs	n/a
3	rs184182998	chr19:52150462-52150463	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Bivalent/Poised TSS	TF binding region	4 gene(s)	Overlapped CNVs	n/a
4	rs150033555	chr19:52150482-52150483	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Bivalent/Poised TSS	TF binding region	4 gene(s)	Overlapped CNVs	n/a
5	rs145537926	chr19:52150494-52150495	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Bivalent/Poised TSS	TF binding region	4 gene(s)	Overlapped CNVs	n/a
6	rs883551	chr19:52150517-52150518	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Bivalent/Poised TSS	TF binding region	4 gene(s)	LD-proxies of rSNP Overlapped rCNV	n/a
7	rs372802581	chr19:52150528-52150529	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Bivalent/Poised TSS	TF binding region	4 gene(s)	Overlapped CNVs	n/a
8	rs373297547	chr19:52150548-52150549	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Bivalent/Poised TSS	TF binding region CpG island	4 gene(s)	Overlapped CNVs	n/a
9	rs566200652	chr19:52150564-52150565	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Bivalent/Poised TSS	TF binding region CpG island	4 gene(s)	Overlapped CNVs	n/a
10	rs142544723	chr19:52150589-52150590	Enhancers Bivalent Enhancer Flanking Active TSS Active TSS Weak transcription Bivalent/Poised TSS	CpG island	4 gene(s)	Overlapped CNVs	n/a
11	rs7359936	chr19:52150601-52150602	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	mRNA abundance
12	rs368876121	chr19:52150710-52150711	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
13	rs537122264	chr19:52150747-52150748	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
14	rs137912786	chr19:52150752-52150753	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
15	rs200040949	chr19:52150753-52150754	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
16	rs555550884	chr19:52150769-52150770	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
17	rs113277778	chr19:52150778-52150779	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
18	rs534479442	chr19:52150784-52150785	Enhancers Flanking Active TSS Weak transcription	n/a	n/a	Overlapped CNVs	n/a
19	rs4801885	chr19:52150811-52150812	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
20	rs569513792	chr19:52150875-52150876	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
21	rs374750726	chr19:52150877-52150878	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
22	rs188585723	chr19:52150887-52150888	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
23	rs113059791	chr19:52150916-52150917	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
24	rs192786376	chr19:52150922-52150923	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
25	rs141914033	chr19:52150940-52150941	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
26	rs576054648	chr19:52150964-52150965	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
27	rs543507617	chr19:52151041-52151042	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
28	rs184873651	chr19:52151047-52151048	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
29	rs113349196	chr19:52151087-52151088	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
30	rs546634044	chr19:52151090-52151091	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
31	rs189296292	chr19:52151092-52151093	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
32	rs138916858	chr19:52151100-52151101	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
33	rs112620884	chr19:52151103-52151104	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
34	rs373923219	chr19:52151106-52151107	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
35	rs180842817	chr19:52151122-52151123	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs186493295	chr19:52151129-52151130	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs140343754	chr19:52151130-52151131	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs150343748	chr19:52151153-52151154	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
39	rs549011359	chr19:52151155-52151156	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs371333620	chr19:52151174-52151175	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs534739691	chr19:52151175-52151176	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs552855980	chr19:52151180-52151181	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs377573742	chr19:52151185-52151186	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs370484818	chr19:52151187-52151188	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs571451930	chr19:52151189-52151190	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs34032047	chr19:52151195-52151196	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs374994978	chr19:52151201-52151202	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs376943861	chr19:52151215-52151216	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs371175723	chr19:52151218-52151219	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs375588166	chr19:52151219-52151220	Enhancers Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:65)

Disease	PMID	Source
Myelodysplastic syndrome	17634407	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Chordoma	21602918	CNVD
Ewing''s sarcoma	21437220	CNVD
Glioblastoma multiforme	21080181	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Cancer	21637783	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Ovarian cancer	21720365	CNVD
Cancer	20164919	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Prostate cancer	18632612	CNVD
Ductal carcinoma	22052326	CNVD
Congenital nephrotic syndrome	18421352	CNVD
Astrocytoma	17934521	CNVD
Leukemia	17361228	CNVD
Adenoid cystic carcinoma	17372589	CNVD
Breast cancer	17603634	CNVD
Glioma	21971842	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Endometrial cancer	22040021	CNVD
Astrocytoma	17387387	CNVD
Breast cancer	21264507	CNVD
Oligodendroglial tumors	17285580	CNVD
renal disease	20603712	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Salivary gland adenoid cystic carcinoma	17545515	CNVD
Breast cancer	16608533	CNVD
Neuroblastoma	18923191	CNVD
Chordoma	18071362	CNVD
Urothelial carcinoma	21177765	CNVD
Metanephric adenoma	20802469	CNVD
Acute myeloid leukemia	16864856	CNVD
Bladder cancer	21909424	CNVD
Medulloblastoma	16783165	CNVD
Acute myeloid leukemia	20729466	CNVD
Ovarian cancer	22174824	CNVD
Multiple myeloma	16616336	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Wilms tumour	21544195	CNVD
low-grade B-cell lymphoma tumor	18367492	CNVD
Congenital anomalies of the kidney and urinary tract	18852474	CNVD
Glioblastoma multiforme	17002787	CNVD
Cervical cancer	21062161	CNVD
Primary central nervous system lymphoma	21088137	CNVD
Prostate cancer	16573809	CNVD
small cell lung cancer	20016488	CNVD
Hodgkin''s lymphoma	18641027	CNVD
Myelofibrosis	22110671	CNVD
Gastric adenocarcinoma	19115996	CNVD
Acute lymphoblastic leukemia	17690704	CNVD
Adrenocortical carcinoma	18281524	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Lung cancer	18438408	CNVD
Basal cell lymphoma	19029149	CNVD
Diffuse large b-cell lymphoma	19029149	CNVD
Colorectal cancer	16272173	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Ovarian cancer	21781307	CNVD
Neuroblastoma	20406844	CNVD
Cancer	20164920	CNVD
Melanoma	17363583	CNVD
Pancreatic cancer	17952125	CNVD
Breast cancer	22522925	CNVD

Chromatin state (count:58 , 50 per page) page: 1 2

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr19:52147200-52153400	Weak transcription	Right Atrium	heart
2	chr19:52149200-52150400	Weak transcription	Spleen	Spleen
3	chr19:52150200-52150400	Bivalent Enhancer	Breast Myoepithelial Primary Cells	Breast
4	chr19:52150200-52150400	Flanking Active TSS	Primary monocytes fromperipheralblood	blood
5	chr19:52150200-52150400	Flanking Active TSS	Primary B cells from peripheral blood	blood
6	chr19:52150200-52150400	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
7	chr19:52150200-52150400	Bivalent Enhancer	Stomach Smooth Muscle	stomach
8	chr19:52150200-52150600	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
9	chr19:52150200-52150600	Flanking Active TSS	Primary B cells from cord blood	blood
10	chr19:52150200-52150600	Flanking Active TSS	Primary hematopoietic stem cells short term culture	blood
11	chr19:52150200-52150600	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
12	chr19:52150200-52150600	Bivalent Enhancer	Adipose Nuclei	Adipose
13	chr19:52150200-52150600	Active TSS	Rectal Mucosa Donor 29	rectum
14	chr19:52150200-52150800	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
15	chr19:52150200-52150800	Enhancers	Primary hematopoietic stem cells	blood
16	chr19:52150200-52150800	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
17	chr19:52150200-52150800	Enhancers	GM12878-XiMat	blood
18	chr19:52150200-52150800	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
19	chr19:52150400-52150600	Enhancers	ES-I3 Cell Line	embryonic stem cell
20	chr19:52150400-52150600	Bivalent Enhancer	H9 Derived Neuron Cultured Cells	ES cell derived
21	chr19:52150400-52150600	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Female	--
22	chr19:52150400-52150600	Bivalent Enhancer	Liver	Liver
23	chr19:52150400-52150600	Bivalent Enhancer	Duodenum Smooth Muscle	Duodenum
24	chr19:52150400-52150600	Bivalent Enhancer	Left Ventricle	heart
25	chr19:52150400-52150600	Bivalent Enhancer	Lung	lung
26	chr19:52150400-52150600	Bivalent/Poised TSS	Skeletal Muscle Female	skeletal muscle
27	chr19:52150400-52150600	Enhancers	Thymus	Thymus
28	chr19:52150400-52151200	Enhancers	Spleen	Spleen
29	chr19:52150400-52151800	Enhancers	Primary B cells from peripheral blood	blood
30	chr19:52150400-52156200	Enhancers	Primary monocytes fromperipheralblood	blood
31	chr19:52150600-52150800	Enhancers	Primary hematopoietic stem cells G-CSF-mobilized Male	--
32	chr19:52150600-52150800	Enhancers	Rectal Mucosa Donor 29	rectum
33	chr19:52150600-52151000	Enhancers	Primary hematopoietic stem cells short term culture	blood
34	chr19:52150600-52153000	Enhancers	Primary B cells from cord blood	blood
35	chr19:52150800-52151800	Enhancers	Primary neutrophils fromperipheralblood	blood
36	chr19:52150800-52154000	Weak transcription	Primary Natural Killer cells fromperipheralblood	blood
37	chr19:52150800-52154200	Weak transcription	GM12878-XiMat	blood
38	chr19:52150800-52154200	Enhancers	Monocytes-CD14+_RO01746	blood
39	chr19:52150800-52155200	Weak transcription	Primary hematopoietic stem cells	blood
40	chr19:52151000-52153600	Weak transcription	Primary hematopoietic stem cells short term culture	blood
41	chr19:52151200-52151800	Weak transcription	Spleen	Spleen
42	chr19:52151800-52152000	Enhancers	Spleen	Spleen
43	chr19:52151800-52152200	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
44	chr19:52151800-52153000	Weak transcription	Primary B cells from peripheral blood	blood
45	chr19:52152200-52154200	Enhancers	Primary neutrophils fromperipheralblood	blood
46	chr19:52153000-52153400	Weak transcription	Primary B cells from cord blood	blood
47	chr19:52153000-52156000	Enhancers	Primary B cells from peripheral blood	blood
48	chr19:52153400-52153800	Enhancers	Right Atrium	heart
49	chr19:52153400-52156400	Enhancers	Primary B cells from cord blood	blood
50	chr19:52153600-52153800	Enhancers	Primary hematopoietic stem cells short term culture	blood

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links